{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T05:42:13Z","timestamp":1761716533731},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:00:00Z","timestamp":1724457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:00:00Z","timestamp":1724457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Tianjin Health Science and Technology Project","award":["TJWJ2023XK020"],"award-info":[{"award-number":["TJWJ2023XK020"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-047A"],"award-info":[{"award-number":["TJYXZDXK-047A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-024-02253-3","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T11:02:55Z","timestamp":1724497375000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Screening and molecular docking verification of feature genes related to phospholipid metabolism in hepatocarcinoma caused by hepatitis B"],"prefix":"10.1186","volume":"23","author":[{"given":"Jian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,24]]},"reference":[{"key":"2253_CR1","doi-asserted-by":"publisher","first-page":"102926","DOI":"10.1016\/j.ebiom.2020.102926","volume":"58","author":"JH Lee","year":"2020","unstructured":"Lee JH, Suh JH, Kang HJ, Choi SY, Jung SW, Lee-Kwon W, et al. Tonicity-responsive enhancer-binding protein promotes stemness of liver cancer and cisplatin resistance. EBioMedicine. 2020;58:102926.","journal-title":"EBioMedicine"},{"key":"2253_CR2","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1038\/s41467-020-16517-w","volume":"11","author":"C Eller","year":"2020","unstructured":"Eller C, Heydmann L, Colpitts CC, El Saghire H, Piccioni F, J\u00fchling F, et al. A genome-wide gain-of-function screen identifies CDKN2C as a HBV host factor. Nat Commun. 2020;11:2707.","journal-title":"Nat Commun"},{"key":"2253_CR3","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41419-024-06493-0","volume":"15","author":"Y Xie","year":"2024","unstructured":"Xie Y, Wu H, He Y, Liu L, Huang IB, Zhou L, et al. Targeting AXL induces tumor-intrinsic immunogenic response in tyrosine kinase inhibitor-resistant liver cancer. Cell Death Dis. 2024;15:110.","journal-title":"Cell Death Dis"},{"key":"2253_CR4","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12967-024-04926-0","volume":"22","author":"Q Yang","year":"2024","unstructured":"Yang Q, Zhuo Z, Qiu X, Luo R, Guo K, Wu H, et al. Adverse clinical outcomes and immunosuppressive microenvironment of RHO-GTPase activation pattern in hepatocellular carcinoma. J Transl Med. 2024;22:122.","journal-title":"J Transl Med"},{"key":"2253_CR5","doi-asserted-by":"publisher","first-page":"100902","DOI":"10.1016\/j.mtbio.2023.100902","volume":"24","author":"W Xu","year":"2024","unstructured":"Xu W, Yang M, Zhang W, Jia W, Zhang H, Zhang Y. Tumor microenvironment responsive nano-platform for overcoming sorafenib resistance of hepatocellular carcinoma. Mater Today Bio. 2024;24:100902.","journal-title":"Mater Today Bio"},{"key":"2253_CR6","first-page":"144","volume":"21","author":"Y Song","year":"2023","unstructured":"Song Y, Lau HC, Zhang X, Yu J. Bile acids, gut microbiota, and therapeutic insights in hepatocellular carcinoma. Cancer Biol Med. 2023;21:144\u201362.","journal-title":"Cancer Biol Med"},{"key":"2253_CR7","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.molcel.2022.03.022","volume":"82","author":"D Liang","year":"2022","unstructured":"Liang D, Minikes AM, Jiang X. Ferroptosis at the intersection of lipid metabolism and cellular signaling. Mol Cell. 2022;82:2215\u201327.","journal-title":"Mol Cell"},{"key":"2253_CR8","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41419-022-05384-6","volume":"13","author":"Q Dang","year":"2022","unstructured":"Dang Q, Sun Z, Wang Y, Wang L, Liu Z, Han X. Ferroptosis: a double-edged sword mediating immune tolerance of cancer. Cell Death Dis. 2022;13:925.","journal-title":"Cell Death Dis"},{"key":"2253_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/978-3-030-35582-1_7","volume":"1223","author":"G Schneider","year":"2020","unstructured":"Schneider G. S1P signaling in the tumor microenvironment. Adv Exp Med Biol. 2020;1223:129\u201353.","journal-title":"Adv Exp Med Biol"},{"key":"2253_CR10","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.jhep.2022.12.028","volume":"78","author":"Y Yin","year":"2023","unstructured":"Yin Y, Sichler A, Ecker J, Laschinger M, Liebisch G, H\u00f6ring M, et al. Gut microbiota promote liver regeneration through hepatic membrane phospholipid biosynthesis. J Hepatol. 2023;78:820\u201335.","journal-title":"J Hepatol"},{"key":"2253_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s12672-024-00922-4","volume":"15","author":"J Meng","year":"2024","unstructured":"Meng J, Yang Z, Jiang X, Zou J. Unveiling NUSAP1 as a common gene signature linking chronic HBV infection and HBV-related HCC. Discov Oncol. 2024;15:61.","journal-title":"Discov Oncol"},{"key":"2253_CR12","doi-asserted-by":"publisher","first-page":"1325992","DOI":"10.3389\/fphar.2023.1325992","volume":"14","author":"S Guo","year":"2023","unstructured":"Guo S, Xing N, Du Q, Luo B, Wang S. Deciphering hepatocellular carcinoma pathogenesis and therapeutics: a study on anoikis, ceRNA regulatory network and traditional Chinese medicine. Front Pharmacol. 2023;14:1325992.","journal-title":"Front Pharmacol"},{"key":"2253_CR13","first-page":"1209","volume":"31","author":"QL Chen","year":"2023","unstructured":"Chen QL, Qiao F, Lu WT, Shi HL, Zhou CX. Bioinformatics analysis of primary biliary cholangitis key genes and molecular mechanisms. Zhonghua Gan Zang Bing Za Zhi. 2023;31:1209\u201316.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"2253_CR14","first-page":"561","volume":"52","author":"Z Xu","year":"2021","unstructured":"Xu Z, Yuan KF. Lipid metabolic reprogramming and metabolic stress in liver cancer. J Sichuan Univ (Med Sci). 2021;52:561\u20135.","journal-title":"J Sichuan Univ (Med Sci)"},{"key":"2253_CR15","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023;79:516\u201337.","journal-title":"J Hepatol"},{"key":"2253_CR16","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1080\/21505594.2022.2028483","volume":"13","author":"YC Chuang","year":"2022","unstructured":"Chuang YC, Tsai KN, Ou JJ. Pathogenicity and virulence of hepatitis B virus. Virulence. 2022;13:258\u201396.","journal-title":"Virulence"},{"key":"2253_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4236\/ojgas.2012.21004","volume":"2","author":"A Estakhri","year":"2012","unstructured":"Estakhri A. The effect of NAFLD (non-alcoholic fatty liver disease) on long-term outcome of chronic hepatitis B in Iranian patients. Open J Gastroenterol. 2012;2:18\u201321.","journal-title":"Open J Gastroenterol"},{"key":"2253_CR18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.14309\/ajg.0000000000001575","volume":"117","author":"P Cacoub","year":"2022","unstructured":"Cacoub P, Asselah T. Hepatitis B virus infection and extra-hepatic manifestations: a systemic disease. Am J Gastroenterol. 2022;117:253\u201363.","journal-title":"Am J Gastroenterol"},{"key":"2253_CR19","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1136\/gutjnl-2020-323153","volume":"71","author":"C P\u00e9neau","year":"2022","unstructured":"P\u00e9neau C, Imbeaud S, La Bella T, Hirsch TZ, Caruso S, Calderaro J, et al. Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma. Gut. 2022;71:616\u201326.","journal-title":"Gut"},{"key":"2253_CR20","doi-asserted-by":"publisher","first-page":"e1541","DOI":"10.1634\/theoncologist.2019-0944","volume":"25","author":"MD Wang","year":"2020","unstructured":"Wang MD, Li C, Liang L, Xing H, Sun LY, Quan B, et al. Early and late recurrence of hepatitis B virus-associated hepatocellular carcinoma. Oncologist. 2020;25:e1541\u201351.","journal-title":"Oncologist"},{"key":"2253_CR21","first-page":"113","volume":"50","author":"Y Shao","year":"2021","unstructured":"Shao Y, Su L, Hao R, Wang Q, Naranmandura H. Advances on molecular mechanism of hepatitis B virus-induced hepatocellular carcinoma. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2021;50:113\u201322.","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"2253_CR22","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1136\/gutjnl-2018-316510","volume":"68","author":"CJ Lim","year":"2019","unstructured":"Lim CJ, Lee YH, Pan L, Lai L, Chua C, Wasser M, et al. Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma. Gut. 2019;68:916\u201327.","journal-title":"Gut"},{"key":"2253_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00262-021-02967-8","volume":"71","author":"L Liu","year":"2022","unstructured":"Liu L, Zhang R, Deng J, Dai X, Zhu X, Fu Q, et al. Construction of TME and identification of crosstalk between malignant cells and macrophages by SPP1 in hepatocellular carcinoma. Cancer Immunol Immunother. 2022;71:121\u201336.","journal-title":"Cancer Immunol Immunother"},{"key":"2253_CR24","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/cac2.12414","volume":"43","author":"JW Eun","year":"2023","unstructured":"Eun JW, Yoon JH, Ahn HR, Kim S, Kim YB, Lim SB, et al. Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib. Cancer Commun (Lond). 2023;43:455\u201379.","journal-title":"Cancer Commun (Lond)"},{"key":"2253_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41421-023-00563-x","volume":"9","author":"H He","year":"2023","unstructured":"He H, Chen S, Fan Z, Dong Y, Wang Y, Li S, et al. Multi-dimensional single-cell characterization revealed suppressive immune microenvironment in AFP-positive hepatocellular carcinoma. Cell Discov. 2023;9:60.","journal-title":"Cell Discov"},{"key":"2253_CR26","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jhep.2021.06.028","volume":"75","author":"L Ma","year":"2021","unstructured":"Ma L, Wang L, Khatib SA, Chang CW, Heinrich S, Dominguez DA, et al. Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Hepatol. 2021;75:1397\u2013408.","journal-title":"J Hepatol"},{"key":"2253_CR27","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s12032-023-02024-7","volume":"40","author":"T Xiang","year":"2023","unstructured":"Xiang T, Cheng N, Huang B, Zhang X, Zeng P. Important oncogenic and immunogenic roles of SPP1 and CSF1 in hepatocellular carcinoma. Med Oncol. 2023;40:158.","journal-title":"Med Oncol"},{"key":"2253_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/metabo13010011","volume":"13","author":"S Chen","year":"2022","unstructured":"Chen S, Tang L, Guillot A, Liu H. Bariatric surgery associates with nonalcoholic steatohepatitis\/hepatocellular carcinoma amelioration via SPP1 suppression. Metabolites. 2022;13:11.","journal-title":"Metabolites"},{"key":"2253_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12906-022-03530-3","volume":"22","author":"S Lu","year":"2022","unstructured":"Lu S, Meng Z, Tan Y, Wu C, Huang Z, Huang J, et al. An advanced network pharmacology study to explore the novel molecular mechanism of compound kushen injection for treating hepatocellular carcinoma by bioinformatics and experimental verification. BMC Complement Med Ther. 2022;22:54.","journal-title":"BMC Complement Med Ther"},{"key":"2253_CR30","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/jnc.15833","volume":"168","author":"M Gok","year":"2024","unstructured":"Gok M, Cicek C, Bodur E. Butyrylcholinesterase in lipid metabolism: a new outlook. J Neurochem. 2024;168:381\u20135.","journal-title":"J Neurochem"},{"key":"2253_CR31","doi-asserted-by":"publisher","first-page":"597527","DOI":"10.3389\/pore.2021.597527","volume":"27","author":"R Zhang","year":"2021","unstructured":"Zhang R, Huang M, Wang H, Wu S, Yao J, Ge Y, et al. Identification of potential biomarkers from hepatocellular carcinoma with MT1 deletion. Pathol Oncol Res. 2021;27:597527.","journal-title":"Pathol Oncol Res"},{"key":"2253_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.7150\/ijbs.87305","volume":"20","author":"Z Yang","year":"2024","unstructured":"Yang Z, Danzeng A, Liu Q, Zeng C, Xu L, Mo J, et al. The role of nuclear receptors in the pathogenesis and treatment of non-alcoholic fatty liver disease. Int J Biol Sci. 2024;20:113\u201326.","journal-title":"Int J Biol Sci"},{"key":"2253_CR33","doi-asserted-by":"publisher","first-page":"1109019","DOI":"10.3389\/fneur.2022.1109019","volume":"13","author":"D Zhu","year":"2022","unstructured":"Zhu D, Zhu Y, Liu L, He X, Fu S. Metabolomic analysis of vascular cognitive impairment due to hepatocellular carcinoma. Front Neurol. 2022;13:1109019.","journal-title":"Front Neurol"},{"key":"2253_CR34","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12957-021-02246-x","volume":"19","author":"G Sun","year":"2021","unstructured":"Sun G, Sun K, Shen C. Human nuclear receptors (NRs) genes have prognostic significance in hepatocellular carcinoma patients. World J Surg Oncol. 2021;19:137.","journal-title":"World J Surg Oncol"},{"key":"2253_CR35","doi-asserted-by":"publisher","first-page":"18174","DOI":"10.1038\/s41598-019-54754-2","volume":"9","author":"Y Tanaka","year":"2019","unstructured":"Tanaka Y, Uchi H, Ito T, Furue M. Indirubin-pregnane X receptor-JNK axis accelerates skin wound healing. Sci Rep. 2019;9:18174.","journal-title":"Sci Rep"},{"key":"2253_CR36","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1016\/j.apsb.2023.05.031","volume":"13","author":"Y Li","year":"2023","unstructured":"Li Y, Li K, Pan T, Xie Q, Cheng Y, Wu X, et al. Translocation of IGF-1R in endoplasmic reticulum enhances SERCA2 activity to trigger Ca2+ (ER) perturbation in hepatocellular carcinoma. Acta Pharm Sin B. 2023;13:3744\u201355.","journal-title":"Acta Pharm Sin B"},{"key":"2253_CR37","doi-asserted-by":"publisher","first-page":"655863","DOI":"10.3389\/fmed.2021.655863","volume":"8","author":"D Wu","year":"2021","unstructured":"Wu D, Zhang L, Ma S, Zhao Y, Chen R, Zhang F, et al. Low growth hormone levels predict poor outcome of hepatitis B virus-related acute-on-chronic liver failure. Front Med (Lausanne). 2021;8:655863.","journal-title":"Front Med (Lausanne)"},{"key":"2253_CR38","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.3390\/ijms22041931","volume":"22","author":"MT Ngo","year":"2021","unstructured":"Ngo MT, Jeng HY, Kuo YC, Nanda JD, Brahmadhi A, Ling TY, et al. The role of IGF\/IGF-1R signaling in hepatocellular carcinomas: stemness-related properties and drug resistance. Int J Mol Sci. 2021;22:1931.","journal-title":"Int J Mol Sci"},{"key":"2253_CR39","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.yexcr.2018.07.002","volume":"370","author":"KO Nielsen","year":"2018","unstructured":"Nielsen KO, Mirza AH, Kaur S, Jacobsen KS, Winther TN, Glebe D, et al. Hepatitis B virus suppresses the secretion of insulin-like growth factor binding protein 1 to facilitate anti-apoptotic IGF-1 effects in HepG2 cells. Exp Cell Res. 2018;370:399\u2013408.","journal-title":"Exp Cell Res"},{"key":"2253_CR40","doi-asserted-by":"publisher","first-page":"101499","DOI":"10.1016\/j.ghir.2022.101499","volume":"66","author":"G Xu","year":"2022","unstructured":"Xu G, Chu J, Shi Y, Huang L, Fu J. The regulation of proliferation and apoptosis in hepatocellular carcinoma via insulin-like growth factor 1 receptor. Growth Horm IGF Res. 2022;66:101499.","journal-title":"Growth Horm IGF Res"},{"key":"2253_CR41","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2147\/JHC.S258930","volume":"7","author":"S Lacin","year":"2020","unstructured":"Lacin S, Yalcin S, Karakas Y, Hassan MM, Amin H, Mohamed YI, et al. Prognostic significance of serum insulin-like growth factor-1 in hepatocellular cancer patients: a validation study. J Hepatocell Carcinoma. 2020;7:143\u201353.","journal-title":"J Hepatocell Carcinoma"},{"key":"2253_CR42","doi-asserted-by":"publisher","first-page":"101482","DOI":"10.1016\/j.ghir.2022.101482","volume":"65","author":"SA Osganian","year":"2022","unstructured":"Osganian SA, Subudhi S, Masia R, Drescher HK, Bartsch LM, Chicote ML, et al. Expression of IGF-1 receptor and GH receptor in hepatic tissue of patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Growth Horm IGF Res. 2022;65:101482.","journal-title":"Growth Horm IGF Res"},{"key":"2253_CR43","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1007\/s11739-023-03339-z","volume":"18","author":"G Tarantino","year":"2023","unstructured":"Tarantino G, Sinatti G, Citro V, Santini SJ, Balsano C. Sarcopenia, a condition shared by various diseases: can we alleviate or delay the progression? Intern Emerg Med. 2023;18:1887\u201395.","journal-title":"Intern Emerg Med"},{"key":"2253_CR44","doi-asserted-by":"publisher","first-page":"e13135","DOI":"10.1111\/acel.13135","volume":"19","author":"JM Hinkley","year":"2020","unstructured":"Hinkley JM, Cornnell HH, Standley RA, Chen EY, Narain NR, Greenwood BP, et al. Older adults with Sarcopenia have distinct skeletal muscle phosphodiester, phosphocreatine, and phospholipid profiles. Aging Cell. 2020;19:e13135.","journal-title":"Aging Cell"},{"key":"2253_CR45","doi-asserted-by":"publisher","first-page":"107155","DOI":"10.1016\/j.phrs.2024.107155","volume":"203","author":"C Tian","year":"2024","unstructured":"Tian C, Huang R, Xiang M. SIRT1: harnessing multiple pathways to hinder NAFLD. Pharmacol Res. 2024;203:107155.","journal-title":"Pharmacol Res"},{"key":"2253_CR46","doi-asserted-by":"publisher","first-page":"392471","DOI":"10.1155\/2015\/392471","volume":"2015","author":"YC Lin","year":"2015","unstructured":"Lin YC, Wu HC, Liao CC, Chou YC, Pan SF, Chiu CM. Secretion of one adipokine Nampt\/Visfatin suppresses the inflammatory stress-induced NF-\u03baB activity and affects nampt-dependent cell viability in Huh-7 cells. Mediators Inflamm. 2015;2015:392471.","journal-title":"Mediators Inflamm"},{"key":"2253_CR47","doi-asserted-by":"publisher","first-page":"853652","DOI":"10.3389\/fcell.2022.853652","volume":"10","author":"CH Lin","year":"2022","unstructured":"Lin CH, Kuo JC, Li D, Koenig AB, Pan A, Yan P, et al. AZD5153, a bivalent BRD4 inhibitor, suppresses hepatocarcinogenesis by altering BRD4 chromosomal landscape and modulating the transcriptome of HCC cells. Front Cell Dev Biol. 2022;10:853652.","journal-title":"Front Cell Dev Biol"},{"key":"2253_CR48","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/hep.32658","volume":"78","author":"X Guo","year":"2023","unstructured":"Guo X, Tan S, Wang T, Sun R, Li S, Tian P, et al. NAD+ salvage governs mitochondrial metabolism, invigorating natural killer cell antitumor immunity. Hepatology. 2023;78:468\u201385.","journal-title":"Hepatology"},{"key":"2253_CR49","first-page":"1006","volume":"29","author":"YX Lin","year":"2021","unstructured":"Lin YX, Chen K, An FM, Wang YF, Wu XB, Zhan Q, et al. Study of abnormal lipid metabolism analysis and significance of fatty acid binding protein expression in patients with hepatocellular carcinoma. Zhonghua Gan Zang Bing Za Zhi. 2021;29:1006\u201313.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"2253_CR50","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11095-021-02998-x","volume":"38","author":"A Eguchi","year":"2021","unstructured":"Eguchi A, Iwasa M. The role of elevated liver-type fatty acid-binding proteins in liver diseases. Pharm Res. 2021;38:89\u201395.","journal-title":"Pharm Res"},{"key":"2253_CR51","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s00428-022-03394-5","volume":"481","author":"D Dum","year":"2022","unstructured":"Dum D, Ocokoljic A, Lennartz M, Hube-Magg C, Reiswich V, H\u00f6flmayer D, et al. FABP1 expression in human tumors: a tissue microarray study on 17,071 tumors. Virchows Arch. 2022;481:945\u201361.","journal-title":"Virchows Arch"},{"key":"2253_CR52","doi-asserted-by":"publisher","first-page":"e007030","DOI":"10.1136\/jitc-2023-007030","volume":"11","author":"W Tang","year":"2023","unstructured":"Tang W, Sun G, Ji GW, Feng T, Zhang Q, Cao H, et al. Single-cell RNA-sequencing atlas reveals an FABP1-dependent immunosuppressive environment in hepatocellular carcinoma. J Immunother Cancer. 2023;11:e007030.","journal-title":"J Immunother Cancer"},{"key":"2253_CR53","doi-asserted-by":"publisher","first-page":"8579658","DOI":"10.1155\/2021\/8579658","volume":"2021","author":"YX Lin","year":"2021","unstructured":"Lin YX, Wu XB, Zheng CW, Zhang QL, Zhang GQ, Chen K, et al. Mechanistic investigation on the regulation of FABP1 by the IL-6\/miR-603 signaling in the pathogenesis of hepatocellular carcinoma. Biomed Res Int. 2021;2021:8579658.","journal-title":"Biomed Res Int"},{"key":"2253_CR54","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/s41588-022-01141-9","volume":"54","author":"D Barkley","year":"2022","unstructured":"Barkley D, Moncada R, Pour M, Liberman DA, Dryg I, Werba G, et al. Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment. Nat Genet. 2022;54:1192\u2013201.","journal-title":"Nat Genet"},{"key":"2253_CR55","doi-asserted-by":"publisher","first-page":"14353","DOI":"10.1016\/S0021-9258(19)49719-6","volume":"267","author":"A Vancura","year":"1992","unstructured":"Vancura A, Haldar D. Regulation of mitochondrial and microsomal phospholipid synthesis by liver fatty acid-binding protein. J Biol Chem. 1992;267:14353\u20139.","journal-title":"J Biol Chem"},{"key":"2253_CR56","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.3892\/or.2017.5946","volume":"38","author":"L Li","year":"2017","unstructured":"Li L, Lei Q, Zhang S, Kong L, Qin B. Screening and identification of key biomarkers in hepatocellular carcinoma: evidence from bioinformatic analysis. Oncol Rep. 2017;38:2607\u201318.","journal-title":"Oncol Rep"},{"key":"2253_CR57","first-page":"133","volume":"43","author":"X Song","year":"2020","unstructured":"Song X, Du R, Gui H, Zhou M, Zhong W, Mao C, et al. Identification of potential hub genes related to the progression and prognosis of hepatocellular carcinoma through integrated bioinformatics analysis. Oncol Rep. 2020;43:133\u201346.","journal-title":"Oncol Rep"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-024-02253-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-024-02253-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-024-02253-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T12:04:10Z","timestamp":1724501050000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-024-02253-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,24]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2253"],"URL":"https:\/\/doi.org\/10.1186\/s12944-024-02253-3","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,24]]},"assertion":[{"value":"25 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committee of Tianjin Third Central Hospital approved the study (Approval No: TJWJ2023XK020).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"268"}}